U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795463) titled 'Botulinum Toxin Type A for Wound Healing After Laparoscopic Colectomy' on Aug. 26.
Brief Summary: This study aims to evaluate the efficacy and safety of botulinum toxin type A (BTX-A) injection as an adjunct to surgical wound healing in patients undergoing laparoscopic colectomy. Eligible participants are randomly assigned in a 1:1 ratio to either an intervention group receiving intradermal BTX-A injection along the surgical incision after wound closure or a control group receiving routine postoperative wound care without BTX-A injection. Wound healing and scar outcomes are evaluated during postoperative follow-up, and adverse event...